{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:40:55Z","timestamp":1788489655182,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA33572"],"award-info":[{"award-number":["P30CA33572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2021C03123"],"award-info":[{"award-number":["2021C03123"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100159"],"award-info":[{"award-number":["82100159"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070151"],"award-info":[{"award-number":["82070151"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100160"],"award-info":[{"award-number":["82100160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370163"],"award-info":[{"award-number":["82370163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA258981"],"award-info":[{"award-number":["CA258981"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA248475"],"award-info":[{"award-number":["CA248475"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100025436","name":"George Hoag Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.medj.2024.07.018","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T10:43:27Z","timestamp":1723718607000},"page":"1510-1524.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Homoharringtonine synergizes with venetoclax in early T\u00a0cell progenitor acute lymphoblastic leukemia: Bench and bed"],"prefix":"10.1016","volume":"5","author":[{"given":"Shanshan","family":"Suo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Xuan Truong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinjun","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjing","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinh Hoa","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Ghoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-9915","authenticated-orcid":false,"given":"Jie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2024.07.018_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.medj.2024.07.018_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.medj.2024.07.018_bib3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.medj.2024.07.018_bib4","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T\u00a0cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.medj.2024.07.018_bib5","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","article-title":"Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations","volume":"121","author":"Neumann","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.medj.2024.07.018_bib6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/bjh.15601","article-title":"Early T-cell precursor lymphoblastic leukaemia: response to FLAG-IDA and high-dose cytarabine with sorafenib after initial refractoriness","volume":"185","author":"Bataller","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.medj.2024.07.018_bib7","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.3324\/haematol.2019.225078","article-title":"Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia","volume":"105","author":"Genesca","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.medj.2024.07.018_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8867760","article-title":"Early T-Cell Precursor Leukemia Has a Higher Risk of Induction-Related Infection among T-Cell Acute Lymphoblastic Leukemia in Adult","volume":"2020","author":"Huang","year":"2020","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.medj.2024.07.018_bib9","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","article-title":"Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.medj.2024.07.018_bib10","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1200\/JCO.20.00572","article-title":"Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy","volume":"38","author":"Chua","year":"2020","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.medj.2024.07.018_bib11","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1200\/JCO.20.03736","article-title":"Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia","volume":"39","author":"DiNardo","year":"2021","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.medj.2024.07.018_bib12","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1158\/2159-8290.CD-14-0353","article-title":"Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199","volume":"4","author":"Chonghaile","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2024.07.018_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010150","article-title":"Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma","volume":"14","author":"Gibson","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.medj.2024.07.018_bib14","article-title":"First report of clinical response to Venetoclax in Early T-cell Precursor Acute Lymphoblastic Leukemia","volume":"2","author":"Numan","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.medj.2024.07.018_bib15","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2014-05-574566","article-title":"ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia","volume":"124","author":"Peirs","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.medj.2024.07.018_bib16","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/2159-8290.CD-18-0140","article-title":"A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia","volume":"8","author":"Ramsey","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2024.07.018_bib17","doi-asserted-by":"crossref","first-page":"70000","DOI":"10.18632\/oncotarget.12132","article-title":"Acquired resistance to venetoclax (ABT-199) in t(14;18) positive lymphoma cells","volume":"7","author":"Bodo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.medj.2024.07.018_bib18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","article-title":"Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2024.07.018_bib19","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3324\/haematol.2019.244020","article-title":"Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models","volume":"106","author":"Singh Mali","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.medj.2024.07.018_bib20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/ejh.13492","article-title":"Pairing MCL-1 inhibition with venetoclax improves therapeutic efficiency of BH3-mimetics in AML","volume":"105","author":"Hormi","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.medj.2024.07.018_bib21","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/1097-0142(20010915)92:6<1591::AID-CNCR1485>3.0.CO;2-U","article-title":"Homoharringtonine: history, current research, and future direction","volume":"92","author":"Kantarjian","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.medj.2024.07.018_bib22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/sj.leu.2404287","article-title":"Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia","volume":"20","author":"Jin","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.medj.2024.07.018_bib23","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1200\/JCO.2000.18.20.3513","article-title":"Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia","volume":"18","author":"Kantarjian","year":"2000","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.medj.2024.07.018_bib24","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1517\/14656566.2013.821464","article-title":"Omacetaxine mepesuccinate (synribo) - newly launched in chronic myeloid leukemia","volume":"14","author":"Nazha","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.medj.2024.07.018_bib25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1470-2045(13)70152-9","article-title":"Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial","volume":"14","author":"Jin","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.medj.2024.07.018_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jmb.2009.04.005","article-title":"U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome","volume":"389","author":"Gurel","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.medj.2024.07.018_bib27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood-2010-01-262808","article-title":"Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia","volume":"117","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.medj.2024.07.018_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13045-023-01437-1","article-title":"Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed\/Refractory AML: A Multicenter, Phase 2 Trial","volume":"16","author":"Jin","year":"2023","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.medj.2024.07.018_bib29","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/leu.2013.377","article-title":"BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines","volume":"28","author":"Anderson","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.medj.2024.07.018_bib30","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1084\/jem.20112239","article-title":"ETV6 mutations in early immature human T\u00a0cell leukemias","volume":"208","author":"Van Vlierberghe","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.medj.2024.07.018_bib31","article-title":"Targeting MCL-1\/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia","volume":"6","author":"Lin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.medj.2024.07.018_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.medj.2024.07.018_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124928","article-title":"Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry","volume":"3","author":"Oetjen","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.medj.2024.07.018_bib34","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3390\/cancers14081873","article-title":"Early T-Cell Precursor ALL and Beyond: Immature and Ambiguous Lineage T-ALL Subsets","volume":"14","author":"Genesca","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.medj.2024.07.018_bib35","first-page":"451","article-title":"The diverse role of the ETS family of transcription factors in cancer","volume":"7","author":"Gilliland","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.medj.2024.07.018_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bcmd.2013.07.010","article-title":"ETS transcription factors in hematopoietic stem cell development","volume":"51","author":"Ciau-Uitz","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.medj.2024.07.018_bib37","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1074\/jbc.M804704200","article-title":"Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia","volume":"284","author":"Wang","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.medj.2024.07.018_bib38","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/onc.2015.174","article-title":"Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets","volume":"35","author":"Collins","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.medj.2024.07.018_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2017.11.005","article-title":"The Ikaros family in lymphocyte development","volume":"51","author":"Heizmann","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.medj.2024.07.018_bib40","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood.2019004547","article-title":"Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL","volume":"137","author":"Anand","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.medj.2024.07.018_bib41","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/cdd.2011.79","article-title":"Nucleolar NF-kappaB\/RelA mediates apoptosis by causing cytoplasmic relocalization of nucleophosmin","volume":"18","author":"Khandelwal","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.medj.2024.07.018_bib42","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1054\/bjoc.2001.2174","article-title":"relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells","volume":"85","author":"Ricca","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.medj.2024.07.018_bib43","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1128\/MCB.01266-09","article-title":"Ubiquitin-independent degradation of antiapoptotic MCL-1","volume":"30","author":"Stewart","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.medj.2024.07.018_bib44","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1073\/pnas.90.8.3516","article-title":"MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2","volume":"90","author":"Kozopas","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2024.07.018_bib45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbamcr.2003.08.012","article-title":"Structural biology of the Bcl-2 family of proteins","volume":"1644","author":"Petros","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.medj.2024.07.018_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164238","article-title":"HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants","volume":"11","author":"Xie","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.medj.2024.07.018_bib47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1756-8722-2-32","article-title":"A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China","volume":"2","author":"Wang","year":"2009","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.medj.2024.07.018_bib48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00277-019-03902-9","article-title":"Relapsed\/refractory early T-cell precursor acute lymphoblastic leukemia was salvaged by venetoclax plus HAG regimen","volume":"99","author":"Zhang","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.medj.2024.07.018_bib49","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3389\/fonc.2020.01423","article-title":"Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.medj.2024.07.018_bib50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/1873-3468.12497","article-title":"Discovery and biological characterization of potent myeloid cell leukemia-1 inhibitors","volume":"591","author":"Lee","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.medj.2024.07.018_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.561","article-title":"Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)","volume":"6","author":"Leverson","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.medj.2024.07.018_bib52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature19830","article-title":"The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models","volume":"538","author":"Kotschy","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.medj.2024.07.018_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2017.12","article-title":"Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells","volume":"2","author":"Luedtke","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.medj.2024.07.018_bib54","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/leu.2011.287","article-title":"MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1\/BIM complex","volume":"26","author":"Konopleva","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.medj.2024.07.018_bib55","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1158\/1535-7163.MCT-15-0730","article-title":"Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models","volume":"15","author":"Punnoose","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.medj.2024.07.018_bib56","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/s41467-018-07551-w","article-title":"Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia","volume":"9","author":"Tron","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2024.07.018_bib57","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood.2021013156","article-title":"Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2","volume":"139","author":"Mill","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.medj.2024.07.018_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/BS9.0000000000000073","article-title":"MYC in T-cell acute lymphoblastic leukemia: functional implications and targeted strategies","volume":"3","author":"Li","year":"2021","journal-title":"Blood Sci."},{"key":"10.1016\/j.medj.2024.07.018_bib59","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2016-09-692582","article-title":"The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia","volume":"129","author":"Sanchez-Martin","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.medj.2024.07.018_bib60","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2141.2011.08955.x","article-title":"Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15","volume":"156","author":"Inukai","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.medj.2024.07.018_bib61","first-page":"977","article-title":"[Characteristics and prognosis in adult patients with early T-cell precursor acute lymphoblastic leukemia]","volume":"39","author":"Gong","year":"2018","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.medj.2024.07.018_bib62","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2011-12-399287","article-title":"Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation","volume":"120","author":"Gokbuget","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.medj.2024.07.018_bib63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.clml.2019.09.608","article-title":"Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia","volume":"20","author":"Richard-Carpentier","year":"2020","journal-title":"Clin. Lymphoma, Myeloma\u00a0& Leukemia"},{"key":"10.1016\/j.medj.2024.07.018_bib64","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2006-11-056754","article-title":"Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801","volume":"109","author":"DeAngelo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.medj.2024.07.018_bib65","first-page":"10","article-title":"Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study","volume":"9","author":"Yamada","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.medj.2024.07.018_bib66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ajh.20903","article-title":"Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia","volume":"83","author":"Zhang","year":"2008","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.medj.2024.07.018_bib67","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.medj.2024.07.018_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.medj.2024.07.018_bib69","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/bloodadvances.2020003902","article-title":"Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia","volume":"5","author":"Patel","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.medj.2024.07.018_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2024.07.018_bib71","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.medj.2024.07.018_bib72","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.medj.2024.07.018_bib73","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2024.07.018_bib74","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2024.07.018_bib75","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nmeth.4402","article-title":"Reversed graph embedding resolves complex single-cell trajectories","volume":"14","author":"Qiu","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.medj.2024.07.018_bib76","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.medj.2024.07.018_bib77","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41467-023-36790-9","article-title":"A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data","volume":"14","author":"De Falco","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2024.07.018_bib78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-0716-1534-8_10","article-title":"Inference of Gene Regulatory Network from Single-Cell Transcriptomic Data Using pySCENIC","volume":"2328","author":"Kumar","year":"2021","journal-title":"Methods Mol. Biol."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634024003003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634024003003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:08:38Z","timestamp":1765595318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634024003003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":78,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2666634024003003"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2024.07.018","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homoharringtonine synergizes with venetoclax in early T\u00a0cell progenitor acute lymphoblastic leukemia: Bench and bed","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2024.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}